Ensysce Biosciences Inc (ENSC)
0.5415
0.00 (0.00%)
USD |
NASDAQ |
May 10, 09:45
Ensysce Biosciences Cash from Investing (TTM): 0.00 for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.0045M |
Date | Value |
---|---|
September 30, 2022 | 0.0045M |
June 30, 2022 | 0.0045M |
March 31, 2022 | 0.0045M |
December 31, 2021 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
Dec 2021
0.0045M
Maximum
Mar 2022
0.002M
Average
--
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Oragenics Inc | -0.9363M |